Lessons Learned in Virtual Launch of an Antenatal Opioid Exposure Study During the COVID-19 Pandemic.
Jamie E Newman, Megan Dhawan, Leslie Clarke and 14 others
PMID 39853217WHAT IT FOUND
234 of 310 infants in an antenatal opioid exposure study attended the 6-month visit; control infants attended more often than opioid-exposed infants (83% vs 72%).
Coordinators used plain-language MRI explanations, non-stigmatizing language, and flexible visits.
Key findings
01234 of 310 infants attended the 6-month visit; control infants attended more often than opioid-exposed infants (83% vs 72%, p = 0.0421).
025% of caregivers of opioid-exposed infants and 8% of caregivers of control infants refused to participate because of MRI requirements (p = 0.328).
0326% of mothers screened positive for food insecurity during pregnancy, and 3 mothers exceeded the depression cutoff.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This paper reports study implementation and 6-month retention, not clinical outcomes or tested interventions. Only the 6-month visit was analysed because later visits had not yet been reached for the full cohort. The study was done at four academic medical centers with Level III NICUs. The retention difference between opioid-exposed and control infants was observed in a non-randomised cohort. Only three mothers exceeded the depression cutoff.
Declared interests
The Eunice Kennedy Shriver National Institute of Child Health and Human Development funded the study through the HEAL initiative, and a NICHD representative was on the steering committee. The authors reported no conflicts of interest.
The easy way to misread this
Do not read the 75% retention rate or the described engagement strategies as evidence that these actions improve clinical care or developmental outcomes. This paper describes a research study's launch and retention, not a tested clinical intervention.